136 related articles for article (PubMed ID: 16206341)
1. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
Cuttner J; Spiera H; Troy K; Wallenstein S
J Rheumatol; 2005 Oct; 32(10):1884-7. PubMed ID: 16206341
[TBL] [Abstract][Full Text] [Related]
2. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
5. Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany.
Richardson DB; Terschüren C; Hoffmann W
Am J Ind Med; 2008 Apr; 51(4):258-68. PubMed ID: 18213641
[TBL] [Abstract][Full Text] [Related]
6. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.
Vamvakas EC
Transfus Med Rev; 2000 Jul; 14(3):258-68. PubMed ID: 10914420
[TBL] [Abstract][Full Text] [Related]
8. Altered immunity as a risk factor for non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Cozen W
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):405-8. PubMed ID: 17337643
[TBL] [Abstract][Full Text] [Related]
9. High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study.
't Mannetje A; Dryson E; Walls C; McLean D; McKenzie F; Maule M; Cheng S; Cunningham C; Kromhout H; Boffetta P; Blair A; Pearce N
Occup Environ Med; 2008 May; 65(5):354-63. PubMed ID: 18032530
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories.
Bernatsky S; Lee JL; Rahme E
Rheumatology (Oxford); 2007 Apr; 46(4):690-4. PubMed ID: 17148471
[TBL] [Abstract][Full Text] [Related]
11. Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States).
Kato I; Koenig KL; Watanabe-Meserve H; Baptiste MS; Lillquist PP; Frizzera G; Burke JS; Moseson M; Shore RE
Cancer Causes Control; 2005 Dec; 16(10):1215-24. PubMed ID: 16215872
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
[TBL] [Abstract][Full Text] [Related]
14. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.
Zhang Y; Holford TR; Leaderer B; Zahm SH; Boyle P; Morton LM; Zhang B; Zou K; Flynn S; Tallini G; Owens PH; Zheng T
Cancer Causes Control; 2004 May; 15(4):419-28. PubMed ID: 15141141
[TBL] [Abstract][Full Text] [Related]
15. [Malignant lymphoma occurring subsequent to autoimmune disease].
Matsunaga T; Maseki N; Kaneko Y; Sampi K; Tsuchimochi T; Sakurai M; Hattori M; Takayama S
Rinsho Ketsueki; 1992 Jun; 33(6):829-33. PubMed ID: 1433925
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM
Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
[TBL] [Abstract][Full Text] [Related]
20. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
